Can You Get COVID-19 Again? Replay our May 22 HDLive!

Follow Our Live Coverage of COVID-19 Developments

Drug Might Lower Heart Attack Risk

Protein inhibitor reduces inflammatory markers in those at high risk

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

En Español

WEDNESDAY, May 11, 2005 (HealthDay News) -- An investigational drug called DG-031 appears to lower inflammatory markers associated with increased heart attack risk, according to a preliminary study in the May 11 issue of the Journal of the American Medical Association.

The study found that the use of DG-031 to inhibit a specific protein, called 5-lipoxygenase activating protein (FLAP), reduced levels of these inflammatory markers in people with certain genetic variants that increase their risk of heart attack.

The study was sponsored by Iceland-based deCODE genetics Inc.

Researchers are currently planning a study to determine whether DG-031 actually reduces heart attack risk.

More information

The American Heart Association has more about heart attack.

SOURCE: JAMA/Archives journals, news release, May 10, 2005


Last Updated: